Related Experiment Videos
Complications of screening flexible sigmoidoscopy.
Theodore R Levin1, Carol Conell, Jean A Shapiro
1Kaiser Permanente Division of Research, Oakland, California 94612, USA. Theodore.Levin@kp.org
Gastroenterology
|November 28, 2002
View abstract on PubMed
Summary
Flexible sigmoidoscopy (FS) for colorectal cancer screening has a modest risk of serious complications. The risk of myocardial infarction (MI) after FS is similar to the expected rate for the screening population.
Area of Science:
- Gastroenterology
- Preventive Medicine
- Clinical Outcomes Research
Background:
- Flexible sigmoidoscopy (FS) is a recommended screening tool for colorectal cancer (CRC).
- Limited data exist on adverse event risks associated with FS in routine clinical practice.
- Understanding these risks is crucial for informed screening recommendations.
Purpose of the Study:
- To determine the incidence of gastrointestinal complications following screening FS.
- To assess the risk of acute myocardial infarction (MI) after screening FS.
- To evaluate the safety profile of FS in a large, general population cohort.
Main Methods:
- A cohort of 107,704 average-risk individuals undergoing screening FS was analyzed.
- Data were collected from the Kaiser Permanente Medical Care Program between 1994 and 1996.
- Hospitalization for gastrointestinal complications or MI within 4 weeks of FS served as the primary outcome measure.
Main Results:
- The overall incidence of gastrointestinal complications requiring hospitalization was low (24/109,534 FS).
- Serious complications, including perforations and bleeding, were infrequent (7/109,534 FS).
- Complications were more common in men, and the incidence of MI post-FS was comparable to baseline rates.
Conclusions:
- Screening flexible sigmoidoscopy demonstrates a modest risk of serious adverse events in general clinical practice.
- The observed incidence of myocardial infarction after FS does not exceed expected rates for the age group.
- These findings support the safety of FS as a colorectal cancer screening modality.